Notifications

Dear User,

Dear Buyers,
Sellers Suspended due to non-compliance with GFR Rule 144(xi):
Sellers and Brands listed in the "Sellers Suspended due to non-compliance with GFR Rule 144(xi) " either been determined as non-compliant or have failed to prove their compliance for clause 26 of GTC. till 31.01.2024.
These sellers, the brands owned by them and all the catalogs uploaded by them have been removed from GeM marketplace. These are not eligible for any bid participation on GeM (even through Custom bid and or BOQ bid modes).
Buyers are advised to ensure that they reject such offers received in any bid process form such sellers or other sellers offering products of these brands because of suspension due to noncompliance of GTC clause 26.
GeM reserves the right to cancel such contracts even if placed by the buyer. Buyers are advised to check updated list on regular basis on GeM.
I have gone through the list of Sellers Suspended due to non-compliance with GFR Rule 144(xi). I confirm that I have rejected all such bids which are form such sellers or other sellers offering products of these brands. I understand that this is not an exhaustive listing and I have also done due diligence in respect of remaining sellers for the compliance of GTC clause 26.
Note:
No EMD to be taken from exempt category of sellers even by way of specific clauses mentioned in ATC / STC. Such clauses which are against the GeM GTC, will be treated as null and void.
However, State Government / State Autonomous / State Local Bodies / State PSU / Cooperatives may choose to seek EMD from MSE bidders by specifying the same in ATC / STC of the Bid. In case no such clause is included in ATC / STC, EMD exemption as per para (m) above shall prevail.
Dear Sir/Ma'am,
A technical issue reported in product bids published/drafted since 14th July 2023 9:00 a.m. . The brand name and related information was mentioned in title of the item for the bid created instead of category name of item. Therefore, buyers are advised to cancel such bids and publish fresh bid by 18th July 2023. These bids shall never be treated as PAC bid and they will be brand neutral unless otherwise created as PAC Bid.
Revised IM Policy effective from 1st July'23 - Click here.
Dear Buyer,
Issue of notification regarding OEM / Compatible Cartridge / Consumable (View More)
Some cases have been reported where bidders have claimed non receipt of prior intimation of RA start. In order to ensure that no prospective eligible bidder is left out due to non intimation on time, it has been decide that RA will henceforth start 24 hours after the buyer proceeds for the RA creation and initiated RA. RA Start date and End Date will be notified to both buyer and sellers.
GeM system maintenance activity is planned from 17/06/2023 9:00 PM until 18/06/2023 02:00 PM. While we will work towards avoiding any outages, the system may be unstable intermittently. As a preventive measure, you are requested to either prepone or postpone Bid related activities such as Bid creation, Evaluation, Seek Clarification, Reply Representation and Negotiations etc, to other dates as per your convenience. Also, you may like to avoid keeping Bid end date and Bid Opening dates on or near these dates if feasible.
Please find enclosed OM dated 28.04.2023 on revised format for Registration of bidders from countries sharing land border with India under Rule 144 (xi) for your kind information and necessary action.
Notification regarding Cyber Security Control matrix
Please note that insecure products, solutions, and services lead to exposure to threats and cyber security breaches which affects procuring entities. Assuring cyber security as a feature of products and services require ensuring cyber security compliances as a part of procurement This will also help in building a cyber-security culture. Building awareness in government agencies to adopt cyber security controls as part of the procurement of ICT products and services, as well as engaging industry to put cyber security control requirements into practise, is crucial for meeting the objective of ensuring cyber security.

It is noted that many times due to lack of awareness various clauses, provisions, and guidelines regarding cyber security requirements mandated by MeitY are not being incorporated while making procurements by buyer organisations. In order to give inputs to the procuring authorities regarding these aspects, Indian Computer Emergency Response Team (CERT-In) drafted a discussion paper regarding cyber security control matrix for the procurement of services and solutions by government organisations. The control matrix includes governance and policy, confidentiality, availability, regulatory complexity, audits and situational awareness, data security, application security, and network security. Discussion paper indicates the specification and requirements of different controls as well as indicative methods for verification for each control matrix. A copy of the discussion paper is enclosed herewith.

All the organisations making procurement through GeM are hereby requested to take note of the discussion paper drafted by CERT-In on "Cyber Security Controls Matrix for Procurement of Services and Solutions by Government Organisations ". which is enclosed as Annexure.

It may be noted that procuring entities may select and include appropriate and applicable controls from the control matrix indicated in the discussion paper as a part of their procurement of ICT services and solutions. Procuring entities may also consider adding additional specific controls as per their risk profile and scope of services.

It may also be noted that the adoption of cyber security controls by procuring entities in the procurement process may be kept voluntary (as best practises). However, after a year, based on the outcomes, learning control may be mandated as a part of all ICT-related procurement by government entities.

All buyer organization as well as seller/service providers are requested to note the above.
Push Button Procurement (PBP) functionality enhanced - No need for buyer to certify reasonableness of rates:
GeM has enhanced the Push button Procurement functionality enabled as per DoE OM number F.6/7/2022-PPD dated 11th January 2023. The new guidelines for PBP are as follow:
1. (a) The total procurement value of the specific case may be up to Rs. Five lakhs inclusive of all taxes (No splitting of requirement to be done to bring procurement under this method).
2. (b) This method will be enabled by GeM only for select categories where at least ten sources are listed, and marketplace is sanitized.
3. (c) Once PBP bid is invited on GEM, contract will be placed directly by Gem System without any human intervention i.e., no evaluation or rejection of bids by buyer and without any need for buyer to certify reasonableness of price. Provided conditions as per DoE OM are satisfied, which would be checked by Gem system, - Not by buyer.
4. (d) GeM system would itself check that at least five bids are received (with minimum two Different brands).
5. (e) Individual bidders may quote more than reference price of PBP. GeM system would ensure that order is placed only if lowest price received after PBP is below the GeM marketplace price for identical requirements.
Please refer push button procurement Manual for detailed guidelines. The details of Categories enabled for PBP are available here.
Buyers are advised to comply the latest OM No.F.7/10/2021-PPD (1) dated 23.02.2023 issued by DoE for the restrictions under Rule 144(xi) of the General Financial Rules (GFRs), 2017 while procuring on GeM.
With reference to the clause 4, Section xiii, Sub-section 'm' of GeM GTC, it is to bring to your kind attention that the following categories of Sellers are exempted from furnishing Bid Security:
1. 1. Micro and Small Enterprises who are manufacturer of the Primary Product Category or Service Provider of the Primary Service Category and give specific confirmation to this effect at the time of bid submission and whose credentials are validated online through Udyam Registration / Udyog Aadhaar (as validated by Government from time to time) and through uploaded supporting documents.
2. 2. Start-ups as recognized by Department of Industrial Policy and Promotion (DIPP).
3. 3. KVIC, ACASH, WDO, Coir Board, TRIFED and Kendriya Bhandar.
4. 4. Sellers who have got their credentials verified through the process of Vendor Assessment by Vendor Assessment Agencies for the Primary Product / Primary Service for which Bid / RA has been invited.
5. 5. Sellers/ Service Provider having annual turnover of INR 500 Crore or more, at least in one of the past three completed financial year(s)
6. 6. Micro and Small Enterprises registered with NSIC for the Primary Product Category whose credentials are validated through NSIC database and through uploaded supporting documents.
7. 7. Micro and Small Enterprises registered with DIC for the Primary Product Category whose credentials are validated through DIC database and through uploaded supporting documents.
8. 8. Sellers / Service Providers holding BIS License for the Primary Product Category whose credentials are validated through BIS database and through uploaded supporting documents.
9. 9. Central / State PSUs.
10. 10. Seller / Service Provider registered with designated Agency / Authority as specified in the bid document by the Buyer – such bidder shall have to upload scanned copy of relevant registration document in place of Bid Security document while ] bidding.
Note: No EMD to be taken from exempt category of sellers even by way of specific clauses mentioned in ATC / STC by the Buyers. Such clauses which are against the GeM GTC, will be treated as null and void.
- Get immediate financing through TReDS to pay your MSMEs and show compliance with MSMED Act.
- Benefits of TReDS:
Easy & speedy financing of MSME receivables at highly competitive rates through multiple bank bidding
Uncollateralized finance for Buyers
Assured compliance to MSMED Act, 2006 for making payment to MSMEs as per the Department of Expenditure Payment Order from Goods acceptance date.
Financing period of maximum 180 days.
Automated repayment to financiers on due date through an auto-debit mechanism.
100% digital transactions from anywhere
Lower administration cost for vendor financing, payments, and settlements
How to avail benefits of TReDS?
Not registered with TReDS? Start registration NOW
M1xchange: https://www.m1xchange.comBenefitstoGeMsupplier&Buyer/
Invoicemart: https://www.invoicemart.com/
RXIL: https://rxil.in/Registration-Benefits-GeM-Buyer.html
Registered with TReDS? Now, choose payment through TReDS
With reference to the OM No.F.6/1/2023-PPD dated 06.01.2023, from Dept. of Expenditure, the minimum service charges for the commission based Manpower Outsourcing services has been revised to 3.85%. Procuring entities can also fix the service charges above 3.85% with proper justification on file, wherever required. However, such service charges should not exceed 7% in any case. It is also recommended to use the Least Cost Selection (LCS) especially in High Value Bids, the template for which can be assessed on this link.
DPIIT has issued OM P-45014/33/2021-BE-II (E-64737) dated December 20th, 2022 related to common examples of "Restrictive and discriminatory conditions against the local suppliers" and "Other conditions which make the bid non compliant to PPP-Mll Order''. Buyers are advised to comply with the same and ensure that their tenders are compliant with PPP-MII Order and don't include restrictive and discriminatory conditions against the local suppliers.
Single packet bid has been enabled on GeM and buyers can procure using it. In single packet bidding both technical and financial offerings are being opened simultaneously and buyers evaluate both financial and technical offers simultaneously and publish the evaluation results. Please refer to the user manual for details.
Additional disclaimer and recommendation for buyers for procurement of Drugs/Medicine through Custom/BOQ bids:
All Provisions of Drugs and Cosmetics Act, 1940 and Rules made there under as amended till date will always be applicable. This will include all notifications issued by Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare (MoHFW) and Department of Pharmaceuticals (DOP), Ministry of Chemicals & Fertilizers from time to time in this regard.

The sellers are registered on GeM based on self-declaration of valid Drug License, product certification, test reports etc. However, buyers mandatorily check and validate the details at their end for all applicable licenses and certifications e.g., validity and authenticity/genuineness of drug license, product certification, manufacturer certification/licenses, test reports etc.

In case of custom/BOQ bid, it is recommended to take Notarized Undertaking from private drug manufacturers for necessary compliances. (attached format of "Notarized Undertaking")

Only manufacturers for particular drugs/medicine may be eligible to participate in the bid or quote for the drugs/medicine.
The service category “Healthcare Human Resource Outsourcing Service” has been merged with the other existing manpower outsourcing services which are Manpower Outsourcing Services - Minimum Wage and Manpower Outsourcing Services - Fixed Remuneration . Hence, it has been disabled from the market for all new bids. Buyers can hire the healthcare resources from these 2 manpower outsourcing service categories. There will be no impact on already published bids.
GeM has launched the Push button procurement functionality on experimental basis enabling buyer to buy upto 5 lakhs simplifying the procurement process and require minimal intervention from buyer. This is system driven procurement enabled for the limited 50 categories . This has been enabled vide DoE OM number F.6/7/2022-PPD dated 11th January 2023. The buyer may refer the push button procurement manual for further details. The details of categories enabled for PBP is available here. The key guidelines for PBP are as follow
1. (a) PBP will be made only on GeM through bidding (PBP through Direct Purchase, L-1, Custom-bid etc. are not permitted).
2. (b) The total procurement value of the specific case is not to exceed Rupees Five lakhs, inclusive of all taxes.
3. (c) This will be additional method of procurement and procuring entities are free to use or not to use this additional method of procurement.
4. (d) This method can be used only in case of at least five bids are received. In case of less than five bids are received, the procurement is to restart using usual procurement methods.
5. (e) No splitting of requirement is to be done so as to bring procurement under this method.
6. (f) Once bid is invited on GeM, contract will be placed directly by GeM without any human intervention. (Provided condition 3 (d) above is complied.)
7. (g) This method will be permitted by GeM only for such categories, where at least ten sources are listed.
Load Based Bidding
Bids are currently being evaluated on GeM based on the price quoted by the bidder at the time of bid participation. However, there are some use cases when the buyer publishes a bid and expects certain technical and commercial parameters to be used to evaluate the price, resulting in the evaluated price being different from the bidder's offered price.

To capture detailed technical and commercial parameters, GeM has added another feature whereby a buyer can declare the Technical and Commercial Loading Criteria for Bid Evaluation during Bid Creation itself, which will be printed for the bidders' reference in the Bid document.

The selection of the Techno Commercial for Bid Evaluation will be optional for the buyer and the same can be saved as "No," if buyer doesn’t wish to go with the same.

This will be used by the buyer for the limited categories available in the GeM marketplace.

Categories where Load based will be applicable - BIOMASS and types of pumps like HSD, Screw , Fuel, Petrol pump.
Bunching of predefined categories has been enabled now for bidding. Buyer can create bunch bid of items from same category. Buyer can also create bunch bid of items from different categories if such categories are enabled for bunching by GeM. If the item categories that you are trying to bunch are not enabled to be bunched together and you feel that these are items are having same Supplier / OEM base and are required to be bought together and bunching will not lead to restriction in competition, then you may please send an email request to GeM at request-bunch@gem.gov.in for enabling bunching of such categories. Please mention exact name of GeM categories that you are requesting for enabling bunching. Your request would be examined by GeM team and if it is found that such bunching would not lead to restrictive bidding, GeM would enable bunching of those categories. This is a one time exercise and once enabled, all buyers can bunch those categories in all their future bids. Custom and BoQ items are by default enabled to be bunched with other regular categories.
The option of acceptance/ rejection of Direct Purchase/ L1 orders will be discontinued on GeM from 29th July 22 onwards. All the orders placed on GeM shall be auto accepted unless the buyer is red flagged or the order is for a freight intensive item. Only in these cases, the sellers will get an option to Accept/ Reject the order. Even in these cases, the order shall be auto accepted in 5 days if no action is taken by the seller.
The functionality for the collection of interest amount on the delayed payments as per DoE OM No.F.6/18/2019-PPD dated 3rd July 2020 is being made live from 01st August 2022, which would be applicable on all CRAC issued/generated on or after 01st August 2022. If the payment is delayed beyond prescribed timelines, the buyer will be liable to deposit interest as per DoE OM. Interests due showing in the Buyer dashboards for older contracts are being reset to zero and all future interests would have to be paid using online functionality deployed on the GeM using the SBI payment gateway.
Please read DO from CEO GeM regarding misuse of Custom / BoQ based bids.
DP and L-1 purchase for multiple consignee is not allowed. Buyer can add multiple consignees during bid creation.
Bunching of the items has been disabled for Direct Purchase and L1 purchase. For ordering multiple items put the items in separate carts and proceed to checkout in each cart.
GeM is in process to phase out the use of OTP based on authentication process at various stages of procurement like bid floating, bid submissions, invoicing, CRAC generation, Bill process, payment etc. For seamless and hassle-free transition it is advised to get yourself registered for esign or DSC based authentication services and complete all associated formalities. The exact date of disablement of the OTP based authentication will be communicated in near future.
GeM is in a process of development of functionality to deal the statutory variations of contract like GST, VAT etc online. In meantime till such functionality is deployed buyers and sellers are advised to deal variation of taxes OFFLINE at their end with due verification and scrutiny as per enforced tax rates, contract clause and applicable guidelines of organization.
Direct RA is being disabled. Please use BID to RA in place of Direct RA.
Escalation of Tickets – Please raise a ticket while flagging any issue to GeM, it helps better tracking, monitoring, and faster resolution. Further it helps in escalating it to higher level if issue is not resolved within defined timeline. Now tickets can be escalated https://gem.gov.in/gemtickets/create to higher level.
Training for registration and bidding for buyers and sellers - GeM offers self-help trainings for buyers and sellers to register and procure services from the GeM portal without any external help. The link to access these training programs is https://gem.gov.in/training/training_module.
Input Tax Credit - Input Tax Credit and Reverse Charge Mechanism feature in BID has been implemented. Input Tax Credit is required by Buyers who are eligible for Input Tax Credit on GST and GST cess (wherever applicable) in their purchase. Since they get credit of GST therefore, they require financial evaluation of BID considering input tax credit (ITC) so that L1 evaluation is on Net landed Cost to the Buyer. There are three types of sellers in this case. One is regular GST registered seller, unregistered seller and seller registered under composition scheme. This functionality is for all goods and services except services on commission base.
Custom bid and BOQ Bid- GeM strongly recommend use of category based bids - Use of Custom Bid / BoQ bid is not allowed for items for which regular category is available on GeM. Buyer can use the features of Additional parameters also to suit its requirement. Any bid created under Custom / BoQ category shall be cancelled by GeM without any notice, if it is found that regular category is available on GeM for similar items.
Creation of secondary user under different primary user with same mail id: The secondary user registration using an existing email address should be allowed for all the roles - Buyer, Consignee and PAO/DDO.
GeM has revised its Transaction Charge policy. This can be accessed at here
Vaccines and Generic Drugs/Medicine categories - Categories of Vaccines required under the Universal Immunization Program (UIP) of MoHFW have been made live in consultation with them. The categories of TB medicines required under National TB program of MoHFW and other generic drugs/medicines have been made live.
Unlimited RA Auto Extensions - Now there is NO limit on number auto-extensions allowed in reverse auctions, GeM recommends use of unlimited auto extension for best price discovery.
Bid opening from 3 days instead of 10 days only for central Gov & Central CPSE buyers and not applicable on BOQ and custom bids.
BID Life cycle from system has been removed from the system for all types of bids/RA.
Technical evaluator: Evaluation can be based on Single/Multiple evaluator(s) or self, selection for Tender Committee (TC) option shall also be available
Re-blocking of funds - Buyers will now be able to block funds which they had not done at the time of order placement due to reasons like change of financial years etc.
- New Functionalities on Services
L1 negotiation: Buyer now gets an option to negotiate with L1 discovered from the financial evaluation. In case service provider has uploaded the price breakup then service provider gets the option to upload revised price breakup after conducting their negotiations with the buyer.
MSE preference: If buyer has selected MSE preference in bid then buyer will get option to send price match request to MSE if Non MSE bidder is selected as L1 and MSE price quoted is within L1+X% (X as defined in bid) range. In case buyer has not opted for MSE preference then buyer needs to provide competent authority approval with detail of approving authority.
Minimum floor price: A new feature has made live to solve the above problem, minimum floor price feature is available for buyers to define the minimum floor price below which no service provider would be able to quote in bid. This feature will help buyers to get reasonable price offers in bids. This feature is available for all PSUs/CPSEs/State Buyers and MoD.
Online invoicing for services - In order to introduce end to end procurement on GeM Invoicing has been made live on GeM for service providers and buyers to streamline the complete process.
Invoice rejection by consignee - Once the invoice raised by service provider, consignee now has the feature to reject the invoice against some rejection reasons which will be visible to service provider. Based on the comments, service provider will be able to update the invoice and then submit again.
Provision to upload additional SLA and SOW and ATC - Buyer has provision to write or upload document files for all of above features which will further become part of bid document and contract document and service provider has to abide by that. The terms and condition, scope of work or SLA mentioned by buyer will supersede by default conditions mentioned in SLA of the service.
Price breakup - GeM has introduced the functionality where Buyer can request for Price Breakup, Format to be uploaded by buyer for the breakup of components on cost/price offered by Service Provider in the Bid. Format uploaded by buyer may be used by service provider as reference for providing financial breakup. L1 will be evaluated by system basis on lowest price offered. GeM restricts this document to be available only during financial evaluation step, buyer will be able to open this document after financial will be open.
Custom filter for buyer - GeM has introduced feature to choose “Others” option from the list of values of technical parameters in case desired parameter is not available. Buyer has to select “Intent of Buying” as “Bid” to enter the Customized Requirement.
GeM system maintenance activity is planned from 25/06/2022 9:00 PM until 26/06/2022 12:00 Noon. While we will work towards avoiding any outages, the system may be unstable intermittently. As a preventive measure, you are requested to either prepone or postpone Bid related activities such as Bid creation, Evaluation, Seek Clarification, Reply Representation and Negotiations etc, to other dates as per your convenience. Also, you may like to avoid keeping Bid end date and Bid Opening dates on or near these dates if feasible. Please note, during this period Buyers can access all previous and ongoing Bid/RA status and details from their panel.
Forward Auction is a new feature addition into GeM platform enabling integrated B2B (Business to Business) and B2C (Business to Customer) auction featuring pan India auctioneers and bidders. As a GeM registered buyer, user can create “Auction” to sell off goods/materials/immovable assets within GeM portal using Forward Auction application and can reach out pan India bidders at a larger scale. To know more, click here
Advanced Search- https://bidplus.gem.gov.in/advance-search
Please click here to view the service approval process flow.
"Buyer Selected Non-Golden Parameters are now mandatory Bid requirement” - Buyers can now choose both Golden and Non-Golden Parameters for defining the Bid Requirements. This will enable Buyers to impose a non-golden parameter as a mandatory specification for their Bids.

All Golden parameters of the category and only those non-Golden parameters which Buyer has selected while creating bid (with values as selected by the Buyer or better than that), will now form part of the overall item specifications in Bid and will be published in the Bid document. Please note that the Non-Golden Parameters which are not specifically selected by the Buyer will now be discarded from bid and will not be published in bid and Sellers can offer a product with any of the allowed values for such non-golden parameters. If buyer want to make any non-golden parameter a part of bid, he must select that parameter and select its allowed values while creating bid, else GeM system would presume that buyer has no specific choice for that parameter and will accept any value for that parameter. No bid can then be rejected for such non selected parameter.
It is also to be noted that the values of the reference product are no longer part of the bid and only allowed values will be part of bid. For Golden parameters, by default GeM would incorporate all values that are better than the reference product's values in the bid. Buyer can select and allow any more values that he feels appropriate so that the bid is as generic as possible to attract maximum competition. Similarly for Buyer chosen non-golden parameters also, reference product's value and better values would be allowed by default and Buyer can add more values of his choice.
Sellers would now need to mandatorily comply with complete Bid specifications to proceed with Bid participation. Since bidders will now be pre-filtered and allowed to offer only those products which are matching with allowed values of Golden as well as non-Golden parameters (Buyer selected), there would now be no need for Buyer's to check or reject any bid on the ground of specification mis-match as far as GeM catalogues are concerned.

Please be informed that all the buyers registered on the GeM portal have to update the GSTIN details mandatorily. You may log into your buyer account and get the option to update GSTIN under the "My Account" section. Also please note that if you do not have a GSTIN number, you will have to give acceptance to the declaration that you are not liable to fall under the ambit of GST on your buyer dashboard.

Request you to please do the needful at the earliest.

Incident management policy has been revised, please click here to view the new policy.
Please click here to see the important updates about the Payments OM
As per the OM issued by the Department of Expenditure, Ministry of Finance (No.F.6/18/2019.PPD), the following provisions have been enabled on GeM -

Proof of Delivery Submission

The system would not allow the seller to generate an invoice, if the delivery period of an order has passed. The sellers must also submit the proof of their delivery to the consignee's location before the delivery date of the orders has passed, for their shipments to be eligible for Auto PRC and Auto CRAC
Auto PRC and Auto CRAC

Auto PRC

In case if the seller has submitted the proof of delivery before the order's delivery date has passed, their shipments would be eligible for auto PRC. This means that if the consignee does not generate the PRC within 4 days from the date of delivery as per the proof of delivery submitted by the seller, then the system would generate an auto PRC, marking all the shipped quantities as PRC accepted. At this point, the consignee would have 2 more days to make any modifications. In case, if still no action has been taken by the consignee within these 2 days, then this system generated auto PRC would be considered as the final PRC which could no longer be modified.
Auto CRAC

In case if the seller has submitted the proof of delivery before the order's delivery date has passed and the final PRC is also completed (through the system or by the consignee), then their shipments would be eligible for auto CRAC. This means that if the consignee has not generated the CRAC within 10 days from the date of delivery as per the proof of delivery submitted by the seller, then the system would generate an auto CRAC, marking all the PRC quantities as CRAC accepted. At this point, the consignee would have 3 more days to make any modifications. In case, if still no action has been taken by the consignee within these 3 days, then this system generated auto CRAC would be considered as the final CRAC which could no longer be modified.
Supplementary Invoice

For product orders where the consignee has made some rejections at the PRC or CRAC stage, the sellers would now have an option to issue a supplementary invoice against these rejected quantities. This option would be available to the seller before the delivery date of the order has passed.

For more information on the OM, please click here.

All transactions on Gem 2.0 can be accessed here.

Home

Pharmaceutical Products incl. Contraceptives and Vaccines

Drugs Affecting the Ears, Eye, Nose and Skin

Combination Antiglaucoma, Ophthalmic, and Eye - Related Agents and Preparations

Brimonidine Tartrate + Timolol Maleate Drops (V2) (Q2 Category)

BRIMOCOM EYE DROPS Brimonidine Tartrate + Timolol Maleate Eye Drop 10 ml Bottle 0.2% + 0.5%

BRIMOCOM EYE DROPS^R

(BRIMONIDINE TARTRATE-2 MG & TIMOLOL MALEATE-5 MG.)

Product Details

Our Price: ₹500.00

Price For : 1 pieces

MRP/Unit: NA

Offer Price/Unit: ₹500.00

Availability: 100000 In Stock

Min. Qty. Per Consignee: 5000

Product id: 5116877-7281056325

Country Of Origin: India

Local Content (MII): 100%

Seller Details

Sold by: OEM

OEM verified catalogue

4.5 - 5.0

View All Sellers

₹500.00

Specifications

Primary pack size 10 ml

Special Terms & Conditions

The sellers are registered on GeM and exempted from the Vendor Assessment process based on the undertaking & submitted copy of a valid Manufacturing Drug License certified by the issuing authority. Buyers must mandatorily ask for submitting the relevant valid drug license and other regulatory documents applicable with the bid. Buyers must also check and validate the details e.g., validity, authenticity/genuineness, name of the drug/medicine under procurement, the license issuing authority etc. at their end.
The Buyer shall ask the seller to submit the “Notarized Undertaking” in the mentioned below format (scanned copy and hard copy). Details of the same may be verified by the buyer at their end.
UNDERTAKING

(to be on non-judicial stamp paper of Rs 10 and notarized)

I, ________________, s/o / d/o / w/o ____________________, aged about _____resident of ___________________________________, do hereby declare and undertake that;
1. I am the partner / proprietor / director of _____________________________(name of entity) and duly authorized to sign this undertaking on behalf of ____________________. (Name of entity)
2. We are the manufacturers of the drug/medicine __________________(“Product”) and intend to offer the same for sale through the GeM portal.
3. We state that the license for the Product has been granted/obtained by us as per the provisions of the Drug & Cosmetics Act, 1940 and rules framed there under as amended till date.
4. We further state that the details regarding the Product/licenses have been uploaded by us on the online ‘SUGAM’ portal of CDSCO as per rule 84AB of the Drugs and Cosmetics Rules, 1945 as amended till date. Reference no. for SUGAM portal is_____________________.
5. We undertake that all the information provided above is true and complete in all respect. We understand that in the event any false information/declaration is provided by us, suitable legal action/action as per Drugs and Cosmetics Act, 1940 as amended till date and rules made there under will be initiated.
Place:

Date:

……………………………………..

Signature, Name, Designation & Seal

on behalf of the Manufacturer
All Provisions of Drugs and Cosmetics Act, 1940 and Rules made there under as amended till date will always be applicable. This will include all notifications issued by Central Drugs Standard Control Organization (CDSCO), Ministry of Health & Family Welfare (MoHFW) and Department of Pharmaceuticals (DOP), Ministry of Chemicals & Fertilizers time to time in this regard.
All provisions of Narcotic Drugs & Psychotropic Substances Act, 1985 as amended till date will also be applicable in case of Narcotic Drugs & Psychotropic Substances.
The purchase shall be made through Bidding/RA only irrespective of the value.
Manufacturer shall have a valid own manufacturing license issued by the competent drug licensing authority defined under the Drugs and Cosmetics Act 1940 and Rules made there under as amended till date. The Drug/medicine quoted should be clearly marked and highlighted in Drug Manufacturing License. The valid own manufacturing license shall be submitted to the buyer at the time of bid submission/delivery as per buyer requirement.
In case of authorized resellers/distributors, it will be the legal & regulatory liability of the manufacturer to ensure that their authorized resellers/distributors are operating in compliance with all relevant laws and regulations and are properly licensed to sell the manufacturer's products.

Manufacturer shall be responsible for verifying the validity and authenticity of drug license held by their authorized resellers/distributors.

If revalidation of drug license has been applied for, the buyer shall be informed accordingly and the copy of application to State Drug / Licensing authority must be submitted with a certificate that application for renewal was made within time frame as per Drug and Cosmetic Act as amended up to date and that has not been deleted by drug licensing authority.
Bidder/Seller shall submit the valid GMP/WHO-GMP Certificate of the manufacturing site as per revised Schedule-‘M’ for the quoted drugs/medicines issued by the Concerned Drug Licensing Authority to the buyer at the time of bid submission.
Bidder/Seller shall submit a valid non-Conviction certificate for last two (2) consecutive years issued by the Concerned Drug Licensing authority to the buyer at the time of bid submission. The certificate must have been issued within 12 months from the date of technical opening of the bid.
Bidder/Seller shall submit Manufacturing & Market Standing certificate (in India) issued by the concerned drug licensing authority for at least latest 2 consecutive years for the drug/medicine quoted to the buyer at the time of bid submission. The drug/medicine quoted should be clearly marked and highlighted.
This would not apply to drugs, which were introduced in India less than 2 years ago. A certificate from the Drug Controller General (India) shall be required for all new drug formulations to this effect.
If a company/firm has two or more separate manufacturing units at different sites / States/region, which are not separate entities then the company will be allowed to submit only one bid for all units but necessary document regarding separate manufacturing units will be submitted to the buyer. However, one bidder will be allowed to submit only one offer for one product.
The manufacturer shall have in house testing facilities and valid Good Laboratory Practice (GLP Certificate) as per Schedule “L1” of the Drugs & Cosmetics Act and Rules made thereunder as amended up to date issued by Central / State Drug Controller / FDA for the quoted drugs/medicines (as applicable).
Bidder/Seller shall have Maximum Production Capacity Certificate (section wise) issued by concerned drug licensing authority highlighting the quoted product.
STP (Standard Testing Procedure) along with the required reference standards for non-Pharmacopoeia drugs/medicines are required to be submitted by the bidder/seller at the time of submission of the bid.
The bidder/seller shall submit complete stability data (long term stability studies and accelerated stability studies) for all drugs/medicines in specified packing for at least 3 batches whenever required by the buyer. For New drugs/medicines, complete stability data of 6 months period shall be acceptable. (If manufacturer has licensed a formula from another company and such licensed formula is used for the product, then the stability data of the licensor should be submitted along with licensing agreement.)
The bidder/seller should have not been blacklisted/debarred/de-registered/banned for the quoted product by any State Government / Central Government / Central or State Government’s Drug procurement agencies at the time of submission of bid. Further, quoted drugs / medicines have not been failed in house testing or testing by any State Government / Central Government / its Drug procurement agencies during last two years. If any bidder/seller has been blacklisted / debarred / de-registered/banned due to quality failure, such bidder/seller or their Partner / Director / Owner shall not be permitted to participate in the bid.
During the validity of the bid if the firm/Company is blacklisted/debarred/de-registered/banned by any State Government / Central Government/Central or State Government’s Drug procurement agencies / convicted by any Court of law in India, it shall be intimated to the buyer along with relevant authentic document by the bidder/seller firm/ company within one month.
During Contract period, if the supplier is debarred/deregistered /blacklisted/ banned by any Central Government or State Government or its procurement agencies due to quality failure, buyer may cancel the contract and go for fresh bid as per discretion of the buyer.
The firm/company/ corporation and any of its director/proprietors/ partners/ Authorized signatories should not be convicted/ or a criminal case filed against or pending in any court of India by any department of Govt. under prevention of Corruption Act or for cheating/ defrauding Government/ embezzlement of Government fund or any criminal conspiracy in the said matter at the time of submission of bid.
Bidder/seller should submit a notarized undertaking on an affidavit of Rs. 100/- (Rupees One Hundred only) duly attested by the Notary stating that:
They will comply with all the statues &legislation regarding manufacturing, import, sale, and supply of drugs in India and in particular the following Acts/Enactments viz., The Drugs and Cosmetics Act, 1940, The Drugs and Cosmetics Rules, 1945 (as amended), The Legal Metrology Act, 2009, The Drugs (Control) Act, 1950, The Indian Statistical Institute Act, 1959, GST Act.

To supply drugs of standard quality as prescribed under the provisions of Drug and Cosmetic Act, 1940 (as amended). The bidder shall also undertake not to supply items/drugs “not of standard”, “Grossly sub-standard” and “Spurious and adulterated drugs” as per the latest guidelines issued by the Drug Controller of India from time to time.
The price offered by the seller/bidder shall not, in any case, exceed the DPCO/NPPA controlled price or price fixed by the State Government, if any. The seller must reduce the prices if there is any reduction in DPCO/NPPA ceiling price or price fixed by State Government, if any.
Guidelines of Department of Pharmaceuticals applicable as nodal ministry for implementing the provision of Public Procurement (Preference to Make in India) order (PPO) 2017-revision as amended to date, related to procurement of Goods & Services in Pharmaceutical Formulations, will be applicable.
Fall Clause: Provision of fall clause will not be applicable on the sale of drugs which have an expiry date as per Ministry of Chemical and Fertilizer OM No 31026/1/2019-Policy dated 12-9-2020.
Shelf Life: Shelf life of each quoted drugs/medicines shall be in accordance with Schedule P of Drugs and Cosmetics Rules, 1945 as amended up to date.
In case pre-dispatch inspection is not applicable, the life of the drugs/medicines shall not have passed more than one sixth (1/6th) of the total shelf life of the drug/medicine at the time of delivery to the consignee.

In case of pre-dispatch inspection, at the time when the stores are offered for inspection, the life of the drugs/medicines shall not have passed more than one sixth (1/6th) of the total shelf life of the drugs/medicines.
Recalls
If products are recalled because of problems with product quality or adverse reaction to the pharmaceutical, the supplier will be obliged to notify the buyer, providing full details about the reason leading to the recall, and shall take steps to replace the product in question at suppliers own cost at the ultimate destination with a fresh batch of acceptable pharmaceuticals or withdraw and give a full refund of the unconsumed quantity if the product has been taken off the market due to safety problems.
Inspection, Testing and Quality Control
- All the batches of the drugs/medicines supplied shall be accompanied with in-house Test Report/Certificate of Analysis from the manufacturer’s own Quality Control Lab. The Test Report/Certificate of Analysis shall include:
1. Generic name of the product
2. Batch No.
3. Pharmacopoeia Reference and/ or In-house method
4. Batch quantity
5. Date of manufacture
6. Expiry date
7. Date of test
8. Description (clarity, color etc)
9. All identity, potency, purity, sterility, pyrogen and all other test required by the specified pharmacopoeia and/or In-house method. Both the actual results and the limits for the individual tests should be given
10. Conclusion
11. Qualified Person’s signature
The above-mentioned batch shall be manufactured in accordance with the applicable GMP regulations.
- Buyer will embark on stringent quality checks to ensure that drugs/medicines/goods meet required standards throughout specified shelf life. The buyer reserves the right to carry necessary inspections/tests from NABL Accredited/Government approved laboratories at any of, or any combination of or/ all following stages:
a) At Pre-Dispatch stage

b) At Delivery Stage: Inspection done once the drugs/medicines/goods reach at consignee location and before taking over supplied goods in inventory.

c) Post Delivery Surveillance: The Drugs/Medicines/goods shall have the active ingredients and all other parameters at the prescribed level as indicated in official compendiums or technical specifications throughout the shelf-life period of the drugs/medicines/ goods. Quality Monitoring Activities may also be organized by the buyer post-delivery.
- The Buyer may engage the services of a Quality Control Agent & Quality Control Testing Laboratories for the purpose of Inspection & Quality Control. The sampling quantities shall be borne by the supplier.
- The buyer’s right to inspect, test and, where necessary reject the drugs/medicines/goods after the drugs/medicines/goods arrival at the final destination shall in no way be limited or waived by reason of the goods having previously been inspected, tested and passed prior to the goods dispatch from the place of manufacture.
- Inspection Methodology: At pre-dispatch and/or delivery stage, samples of supplies in each batch will be chosen for testing. The samples will be collected and sent to designated laboratories (NABL Accredited/Government approved laboratories) for testing as decided by the buyer.
  
  At post-delivery surveillance - The samples will be collected from the warehouse of buyer/or final consignee in States/UTs and sent to designated Quality Control Labs in respect of supplied drugs/medicines/goods at any point during specified shelf life as per decision of the buyer.
  
  Handling and testing charges will be borne by the buyer for the above purpose.
- In case of failure of batches during or at any stage (indicated above), the testing charges would be claimed for the defaulting vendor.
- The supplies will be deemed to be completed only upon receipt of the quality certificates from the laboratories.
  “Not of Standard Quality” or spurious or adulterated or misbranded, such batch/ batches will be deemed to be rejected goods.”
- At any of testing stage, Samples which do not meet quality requirement shall render the relevant batches liable to be rejected. If the sample is declared to be “Not of Standard Quality” or spurious or adulterated or misbranded, such batch/batches will be deemed to be rejected drugs/medicines/goods and the cost of entire batch paid will be recovered from the supplier whether consumed fully/partially.
- If any inspected or tested drugs/medicines/goods fails to conform to the specifications or fails in quality tests, the buyer may reject them, and the supplier will be responsible to take back the rejected drugs/medicines/goods from the depots/consignee place at their own cost and replace with fresh stock duly inspected and tested within 45 days from the date of intimation from the buyer to the supplier or as specified by the buyer. The buyer has the right to destroy such rejected drugs/medicines/goods if the supplier does not take back the drugs/medicines/goods within the stipulated time. The buyer will arrange to destroy the “NOT OF STANDARD QUALITY ITEMS” after the expiry of 45 days.
  
  Action may also be initiated by the buyer for debarring/blacklisting against the supplier for suitable period. The FDA/ Drugs Control Authority of concerned State will also be informed by the buyer for initiating necessary action on the supplier in their state. In addition, Security deposit will also be forfeited without any intimation.
  
  The decision of the buyer or any officer authorized by buyer, as to the quality of the supplied drugs, medicines etc., shall be final and binding.
- In case any drug/medicine is found substandard either any of testing stage or during the shelf life of the item, the report of the NABL/Government approved laboratory shall be accepted by the supplier/seller. If the same is disputed by the supplier/seller giving the reasons, the sample will be sent to Central Drug Laboratory, Kolkata, and the report of CDL will only be accepted as final and conclusive report. However, the same should be submitted within three months, from the date of communication of the disputed test report to the supplier/seller. For this, supplier/seller should approach the concerned Drug Control Authorities for getting the drugs/medicines tested, as per procedure, from the Appellate Laboratory at their own cost.
  
  The de-registration / debarment action will be taken by the buyer against the manufacturing unit and contract holding firms (both) according to the category-A and category-B defects as per guidelines issued by the Ministry of Health & Family Welfare, Government of India and same will be communicated to GeM.
- The supplier shall furnish evidence of the basis for shelf life and other stability data concerning the commercial final package on request by the buyer. In case of any complaint in the field, the B.M.R/ B.P.R for the particular batch of the product(s) supplied shall be produced when demanded. For New drugs/medicines, complete stability data of 6 months period shall be acceptable.
- The case of admixture of drugs will be treated as a violation of terms and conditions and will not be accepted.
- Statutory provisions on manufacture, distribution, storage and quality issues of drugs/medicines under the Drugs & Cosmetic Act, 1940 as amended up to date is vested with the DCGI (CDSCO)/ MoH& FW, including its Central/ Zonal/ Regional Drug Testing Labs. Similarly, the authority for confiscation, sealing or prosecution with relation to drugs/medicines under the said Act is also with the DCGI/ State Drug Control Authorities.
- In accordance with the provisions of Sec 22 & 31 of the Drugs and Cosmetic Act, 1940, as amended up to date, the DCGI/ CDSCO/ State Drug Controller/ Drug Inspector may exercise their powers as an Inspecting Agency.
Deduction, Blacklisting, and other penalties on account of Quality failure
The suitable conditions may be added by the buyer in the bid through Additional Term & Conditions (ATC) as applicable.
Quality Test by Statutory Authorities:
If any batch of any product(s) supplied by the supplier is declared “NOT OF STANDARD QUALITY”, by any government agencies or drug licensing authority, the supplier shall inform the same immediately to the buyer so that the use of the available stock of the particular item will be stopped. Further, the available stock of the product with all consignee/users will be retrieved.
Termination for Default
The buyer may without prejudice to any other remedy for breach of contract, by written notice of default sent to the supplier, terminate the contract in whole or in part If the supplier fails to promptly replace any drug/medicine/goods rejected submitted for testing or subject to recall ordered by the applicable Regulatory Authority in the country of manufacture due to unacceptable quality or reports of adverse drugs reaction after giving prompt notice of the recall.

Warranty

Supplies must fully comply in all respect with the Technical specifications and conditions laid down in the contract and in accordance with the Pharmacopoeia standards.
Each supply should be accompanied with a "Warranty Certificate" duly signed by the Bidder as under:
“The Supplier/Seller hereby declares that the stores as detailed below sold to the buyer under this contract shall be of the best quality and workmanship and shall be strictly in accordance with the specifications and particulars mentioned and the supplier/seller hereby guarantees that the stores would continue to conform to the description of and quality aforesaid for a period of useful life of minimum of five sixth (5/6th) of the specified shelf life from the date of delivery of the said stores to the buyer, have overages within the ranges set forth in the technical specification and are not subject to recall by the applicable Regulatory Authority due to unacceptable quality or adverse Pharmaceuticals reaction. Notwithstanding the above, the fact that the said stores fail to conform to the description and quality aforesaid or have deteriorated and the decision of the buyer in that behalf is final and conclusive, the buyer will be entitled to reject the said stores, or such part thereof as may be discovered not to conform to the said description and quality. Losses due to premature deterioration due to biological and other activities during life potency will be made good and supplied by the firm at its own cost at consignee’s site.

On such rejection, the stores will be at the seller's risk and all provisions herein contained relating to the rejection of stores shall apply. The supplier/Seller shall if so called upon to do so by the buyer in writing, replace the stores free of cost at the ultimate destination within a period of forty five days or such further period as may be extended from time to time by the buyer at his discretion, on application made there under by the supplier/seller after the stores or such portion of the stores thereof as is rejected by the buyer and in such an event the above mentioned warranty period shall apply to the stores replaced from the date of the replacement thereof otherwise the supplier/seller shall pay to the buyer such damage as may arise by reason of the breach of the conditions. Nothing herein contained shall prejudice any other rights of the buyer in that behalf under this contract or otherwise".

Sl. No. & Date	Nomenclature & Specification	Name & Address of Manufacturing Unit	Batch No.	DOM & DOE	Qty. of each batch	Remarks

Signature name & designation and date with rubber stamp

If the supplier, having been notified, fails to replace within the period specified above, the buyer may proceed to take such remedial action(s) as may be necessary/deemed fit by the buyer, at the suppliers' risk and expense and without prejudice to other rights which the buyer may have against the supplier under the contract.

Packaging, Labelling and Marking Requirements
Packaging, Labelling and Marking shall be as per the provisions contained in the Drugs and Cosmetics Act, 1940 and the Rules made there under as amended up-to-date, other particulars of packaging, labelling & marking, if any, prescribed by the buyer in the bid through Additional Terms and Conditions (ATC) shall be complied with.
Bar Coding
All drugs/medicines supplied should incorporate GS1 barcodes standards at various packaging levels (primary, secondary, and tertiary level packaging) and should encode the information within the barcodes as mentioned by the buyers in addition to other existing statutory labelling and marking requirements. Details of bar-coding will be given by the buyer through Additional Terms and Conditions (ATC) in the bid.
Delivery Period
- Minimum delivery period will be of 45 days from the date of issuing of the purchase
- The supplier should maintain the recommended temperature of the drug/medicine (wherever indicated) during transit, otherwise if on checking it is found that temperature has not been maintained, supply against the said order is liable to be rejected and cancelled.
- The items requiring special cold storage conditions shall be supplied with cold chain transporting system under cold chain norms from the manufacturing unit to the warehouses/consignee location.
Any specific requirements for the packaging, labelling, logograms, printing, artwork, bar coding or any other requirement mentioned by the buyer through Additional Terms and Conditions (ATC) in the bid will be applicable.
Any other Terms and Conditions which is not included or at variance with the conditions specified in STC & GTC, may be added by the buyer through Additional Terms and Conditions (ATC) in the bid to ensure drugs/medicines are procured from authentic/validated source with appropriate and applicable quality. The above terms and conditions are in reverse order of precedence i.e., ATC shall supersede specific Special Terms and Condistions (STC) which shall supersede General Terms and Conditions (GTC), whenever there are any conflicting provisions.

Features

PRODUCT INFORMATION

Medicine Name	Brimonidine Tartrate + Timolol Maleate
Dosage Form	Eye Drop
Conformity to pharmacopoeia as per license	In-House Specifications (IHS)
Strength	0.2% + 0.5%
Compliance to uploaded Special Terms and Conditions	Yes

PACKAGING

Type of primary packing	Bottle
Primary pack size	10 ml

CERTIFICATIONS & REPORTS

Availability of valid drug manufacturing license issued from the competent authority defined under Drugs and Cosmetic Act and Rules there under as amended till date	Yes
Valid Drug Manufacturing License Number	148/UA/LL/SC/P-2007
Submission of all necessary certifications, licenses and test reports to the buyer as per buyer requirement at the time of bid submission and along with supplies	Yes